Survival Rates Doubled By Combining Liver Cancer Treatments, UVA Researchers Find

By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct.

More: continued here

Filed under: Liver Disease / Hepatitis on April 17th, 2008